Photocure (PHO) - Net Assets

Latest as of June 2026: Nkr606.75 Million NOK ≈ $63.85 Million USD

Based on the latest financial reports, Photocure (PHO) has net assets worth Nkr606.75 Million NOK (≈ $63.85 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Nkr901.41 Million ≈ $94.85 Million USD) and total liabilities (Nkr294.67 Million ≈ $31.01 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check PHO PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric Value
Current Net Assets Nkr606.75 Million
% of Total Assets 67.31%
Annual Growth Rate 1.22%
5-Year Change -3.66%
10-Year Change 92.2%
Growth Volatility 119.87

Photocure - Net Assets Trend (2000–2025)

This chart illustrates how Photocure's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see PHO market cap overview.

Annual Net Assets for Photocure (2000–2025)

The table below shows the annual net assets of Photocure from 2000 to 2025. Also explore Photocure (PHO) net asset momentum to track the company's year-over-year net asset growth rate.

Year Net Assets Change
2025-12-31 Nkr484.23 Million
≈ $50.96 Million
-3.49%
2024-12-31 Nkr501.72 Million
≈ $52.79 Million
+3.91%
2023-12-31 Nkr482.85 Million
≈ $50.81 Million
+4.35%
2022-12-31 Nkr462.73 Million
≈ $48.69 Million
-7.94%
2021-12-31 Nkr502.63 Million
≈ $52.89 Million
-1.08%
2020-12-31 Nkr508.13 Million
≈ $53.47 Million
+143.60%
2019-12-31 Nkr208.59 Million
≈ $21.95 Million
+18.29%
2018-12-31 Nkr176.34 Million
≈ $18.56 Million
-19.14%
2017-12-31 Nkr218.08 Million
≈ $22.95 Million
-13.44%
2016-12-31 Nkr251.94 Million
≈ $26.51 Million
+19.94%
2015-12-31 Nkr210.06 Million
≈ $22.10 Million
-12.50%
2014-12-31 Nkr240.06 Million
≈ $25.26 Million
-10.80%
2013-12-31 Nkr269.12 Million
≈ $28.32 Million
-29.23%
2012-12-31 Nkr380.27 Million
≈ $40.02 Million
-13.45%
2011-12-31 Nkr439.34 Million
≈ $46.23 Million
-4.25%
2010-12-31 Nkr458.85 Million
≈ $48.28 Million
+10.36%
2009-12-31 Nkr415.78 Million
≈ $43.75 Million
+108.21%
2008-12-31 Nkr199.69 Million
≈ $21.01 Million
-23.19%
2007-12-31 Nkr259.99 Million
≈ $27.36 Million
-20.48%
2006-12-31 Nkr326.94 Million
≈ $34.40 Million
+574.58%
2005-12-31 Nkr48.47 Million
≈ $5.10 Million
-43.36%
2004-12-31 Nkr85.57 Million
≈ $9.00 Million
-35.13%
2003-12-31 Nkr131.90 Million
≈ $13.88 Million
-21.02%
2002-12-31 Nkr167.00 Million
≈ $17.57 Million
-35.62%
2001-12-31 Nkr259.40 Million
≈ $27.30 Million
-27.41%
2000-12-31 Nkr357.36 Million
≈ $37.60 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Photocure's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 2541000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock Nkr13.56 Million 2.80%
Other Components Nkr496.08 Million 102.45%
Total Equity Nkr484.23 Million 100.00%

Photocure Competitors by Market Cap

The table below lists competitors of Photocure ranked by their market capitalization.

Company Market Cap
Hooker Furniture Corporation
NASDAQ:HOFT
$141.15 Million
Moller Y Perez
SN:MOLLER
$141.19 Million
HIM International Music
TWO:8446
$141.20 Million
Hanjin Transportation Co. Ltd.
KO:002320
$141.20 Million
Espey Mfg & Electronics Corp
NYSE MKT:ESP
$141.00 Million
Atrem S.A.
WAR:ATR
$140.98 Million
Sunko Ink Co Ltd
TW:1721
$140.96 Million
Lucky Cement Co
TW:1108
$140.90 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Photocure's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 501,716,000 to 484,231,000, a change of -17,485,000 (-3.5%).
  • Net loss of 1,518,000 reduced equity.
  • Share repurchases of 29,681,000 reduced equity.
  • Other factors increased equity by 13,714,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income Nkr-1.52 Million -0.31%
Share Repurchases Nkr29.68 Million -6.13%
Other Changes Nkr13.71 Million +2.83%
Total Change Nkr- -3.49%

Book Value vs Market Value Analysis

This analysis compares Photocure's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.74x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 5.19x to 2.74x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2002-12-31 Nkr9.59 Nkr49.80 x
2003-12-31 Nkr7.48 Nkr49.80 x
2004-12-31 Nkr4.86 Nkr49.80 x
2005-12-31 Nkr2.75 Nkr49.80 x
2006-12-31 Nkr15.30 Nkr49.80 x
2007-12-31 Nkr11.70 Nkr49.80 x
2008-12-31 Nkr9.04 Nkr49.80 x
2009-12-31 Nkr18.82 Nkr49.80 x
2010-12-31 Nkr20.99 Nkr49.80 x
2011-12-31 Nkr20.39 Nkr49.80 x
2012-12-31 Nkr17.81 Nkr49.80 x
2013-12-31 Nkr12.63 Nkr49.80 x
2014-12-31 Nkr11.25 Nkr49.80 x
2015-12-31 Nkr9.78 Nkr49.80 x
2016-12-31 Nkr11.70 Nkr49.80 x
2017-12-31 Nkr10.12 Nkr49.80 x
2018-12-31 Nkr8.15 Nkr49.80 x
2019-12-31 Nkr9.55 Nkr49.80 x
2020-12-31 Nkr20.49 Nkr49.80 x
2021-12-31 Nkr18.54 Nkr49.80 x
2022-12-31 Nkr17.04 Nkr49.80 x
2023-12-31 Nkr17.81 Nkr49.80 x
2024-12-31 Nkr18.51 Nkr49.80 x
2025-12-31 Nkr18.20 Nkr49.80 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Photocure utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -0.31%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -0.29%
  • • Asset Turnover: 0.75x
  • • Equity Multiplier: 1.46x
  • Recent ROE (-0.31%) is above the historical average (-11.49%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2002 -57.49% -380.62% 0.08x 1.79x Nkr-112.70 Million
2003 -32.65% -77.54% 0.24x 1.78x Nkr-55.87 Million
2004 -52.73% -57.87% 0.45x 2.03x Nkr-53.57 Million
2005 -78.84% -71.23% 0.51x 2.18x Nkr-43.06 Million
2006 26.02% 40.45% 0.56x 1.15x Nkr52.39 Million
2007 -28.94% -75.72% 0.33x 1.16x Nkr-100.87 Million
2008 -32.24% -62.98% 0.43x 1.19x Nkr-84.35 Million
2009 75.13% 645.04% 0.11x 1.10x Nkr270.80 Million
2010 3.94% 10.20% 0.35x 1.12x Nkr-27.79 Million
2011 -1.71% -6.50% 0.23x 1.16x Nkr-51.45 Million
2012 -12.60% -35.79% 0.31x 1.14x Nkr-85.93 Million
2013 -21.90% -70.50% 0.28x 1.12x Nkr-85.86 Million
2014 -10.29% -19.15% 0.48x 1.13x Nkr-48.71 Million
2015 -17.22% -26.85% 0.54x 1.18x Nkr-57.18 Million
2016 14.01% 24.58% 0.50x 1.13x Nkr10.11 Million
2017 -15.91% -22.99% 0.57x 1.21x Nkr-56.51 Million
2018 -20.82% -20.22% 0.79x 1.31x Nkr-54.34 Million
2019 15.26% 11.31% 1.09x 1.23x Nkr10.97 Million
2020 -4.41% -8.73% 0.33x 1.53x Nkr-73.22 Million
2021 -6.15% -8.57% 0.46x 1.57x Nkr-81.16 Million
2022 -15.53% -18.28% 0.55x 1.55x Nkr-118.13 Million
2023 0.20% 0.20% 0.70x 1.47x Nkr-47.31 Million
2024 -0.67% -0.64% 0.71x 1.47x Nkr-53.51 Million
2025 -0.31% -0.29% 0.75x 1.46x Nkr-49.94 Million

Industry Comparison

This section compares Photocure's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $328,814,000
  • Average return on equity (ROE) among peers: 22.73%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Photocure (PHO) Nkr606.75 Million -57.49% 0.49x $141.05 Million
Vistin Pharma ASA (VISTN) $328.81 Million 22.73% 0.34x $85.16 Million

About Photocure

OL:PHO Norway Drug Manufacturers - Specialty & Generic
Market Cap
$141.05 Million
Nkr1.34 Billion NOK
Market Cap Rank
#17945 Global
#156 in Norway
Share Price
Nkr49.80
Change (1 day)
-1.97%
52-Week Range
Nkr48.10 - Nkr79.00
All Time High
Nkr150.90
About

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through two segments, Commercial Franchise and Development Portfolio. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It is also developing Cevira, a photodynamic drug-device combination pro… Read more